Lite ENSAM: a lightweight cancer segmentation model for 3D Computed Tomography

arXiv — cs.CVTuesday, November 4, 2025 at 5:00:00 AM

Lite ENSAM: a lightweight cancer segmentation model for 3D Computed Tomography

The introduction of Lite ENSAM, a lightweight cancer segmentation model for 3D Computed Tomography, marks a significant advancement in cancer treatment evaluation. This model aims to improve the accuracy of tumor size measurements, which are crucial for assessing treatment responses. Unlike the traditional RECIST v1.1 method that measures tumor diameter in a single plane, Lite ENSAM utilizes volumetric measurements, offering a more reliable assessment. This innovation could enhance clinical practices and ultimately lead to better patient outcomes in cancer care.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Disentangling Causal Substructures for Interpretable and Generalizable Drug Synergy Prediction
PositiveArtificial Intelligence
A new framework called CausalDDS has been introduced to improve drug synergy prediction, which is vital for developing effective combination therapies for complex diseases like cancer. Unlike traditional methods that often act as black boxes, CausalDDS aims to provide clearer insights by disentangling drug molecules into causal components.
Robust Atypical Mitosis Classification with DenseNet121: Stain-Aware Augmentation and Hybrid Loss for Domain Generalization
PositiveArtificial Intelligence
A new framework using DenseNet-121 has been developed to improve the classification of atypical mitotic figures, which are crucial indicators of tumor aggressiveness in histopathology. This method addresses challenges like class imbalance and variability in imaging, making it a significant advancement for researchers and clinicians. By incorporating stain-aware augmentation and various transformations, this approach aims to enhance the reliability of mitosis recognition, ultimately aiding in better cancer diagnosis and treatment.